Evidence map›Paper›PMID 22238455›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

IL-21 can supplement suboptimal Lck-independent MAPK activation in a STAT-3-dependent manner in human CD8(+) T cells.

Osamu Imataki, Sascha Ansén, Makito Tanaka, Marcus O Butler, Alla Berezovskaya, Matthew I Milstein, Kiyotaka Kuzushima, Lee M Nadler, Naoto Hirano

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Osamu ImatakiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Sascha Ansén
Makito Tanaka
Marcus O Butler
Alla Berezovskaya
Matthew I Milstein
Kiyotaka Kuzushima
Lee M Nadler
Naoto Hirano
Harvard University · USBrigham and Women's Hospital · USDana-Farber Cancer Institute · USAichi Cancer Center · JPUniversity of Toronto · CA

Funding

Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive ImmunotherapyR01CA148673 · NCI · UNIVERSITY HEALTH NETWORK · PI HIRANO, NAOTO · 2010 to 2014
$1.2M
Generation of Comprehensive Anti-Survivin T Cell Immunity Using an Artificial APCK22CA129240 · NCI · DANA-FARBER CANCER INST · PI HIRANO, NAOTO · 2007 to 2009
$486k
NCI NIH HHS K22 CA129240NCI NIH HHS K22CA129240NCI NIH HHS R01 CA148673NCI NIH HHS R01CA148673
6 · The paper itself

Abstract

Although both MHC class II/CD8α double-knockout and CD8β null mice show a defect in the development of MHC class I-restricted CD8(+) T cells in the thymus, they possess low numbers of high-avidity peripheral CTL with limited clonality and are able to contain acute and chronic infections. These in vivo data suggest that the CD8 coreceptor is not absolutely necessary for the generation of Ag-specific CTL. Lack of CD8 association causes partial TCR signaling because of the absence of CD8/Lck recruitment to the proximity of the MHC/TCR complex, resulting in suboptimal MAPK activation. Therefore, there should exist a signaling mechanism that can supplement partial TCR activation caused by the lack of CD8 association. In this human study, we have shown that CD8-independent stimulation of Ag-specific CTL previously primed in the presence of CD8 coligation, either in vivo or in vitro, induced severely impaired in vitro proliferation. When naive CD8(+) T cells were primed in the absence of CD8 binding and subsequently restimulated in the presence of CD8 coligation, the proliferation of Ag-specific CTL was also severely hampered. However, when CD8-independent T cell priming and restimulation were supplemented with IL-21, Ag-specific CD8(+) CTL expanded in two of six individuals tested. We found that IL-21 rescued partial MAPK activation in a STAT3- but not STAT1-dependent manner. These results suggest that CD8 coligation is critical for the expansion of postthymic peripheral Ag-specific CTL in humans. However, STAT3-mediated IL-21 signaling can supplement partial TCR signaling caused by the lack of CD8 association.

Indexed as

CD8 AntigensCD8-Positive T-LymphocytesCells, CulturedHumansInterleukin-21InterleukinsLymphocyte ActivationLymphocyte Specific Protein Tyrosine Kinase p56(lck)Major Histocompatibility ComplexMitogen-Activated Protein KinasesSignal TransductionSTAT3 Transcription FactorT-Lymphocytes, CytotoxicCD8 AntigensInterleukin-21InterleukinsLymphocyte Specific Protein Tyrosine Kinase p56(lck)Mitogen-Activated Protein KinasesSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID22238455
PMCPMC3273545
OpenAlexW1960168608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.